Quadratus Lumborum Block for Total Hip Arthroplasty

a study on Postoperative Pain Hip Replacement

Summary

Eligibility
for people ages 18 years and up (full criteria)
Location
at Santa Monica, California
Dates
study started
completion around
Principal Investigator
by Pamela Chia, MD

Description

Summary

The quadratus lumborum (QL) block is a fascial plane block that has been described to provide analgesia from T7-L3 dermatomes. The investigators aim to evaluate the efficacy of QL blocks in patients undergoing primary total hip arthroplasty (THA).

Official Title

Quadratus Lumborum (QL) Nerve Block for Patients Undergoing Primary Total Hip Arthroplasty (THA)

Details

Investigators will enroll subjects planned for primary THA and allocate them into receiving a QL block with either saline or ropivacaine. Primary outcome will be pain scores over the first 48 hours after surgery.

Keywords

Pain, Postoperative, quadratus lumborum nerve block, analgesia, total hip arthroplasty, postoperative outcomes, Postoperative Pain, Active Comparator

Eligibility

You can join if…

Open to people ages 18 years and up

  • Adult subjects undergoing elective primary total hip arthroplasty

You CAN'T join if...

  • patients age < 18,
  • documented allergy to local anesthetic
  • presence of peripheral neuropathy
  • patients with current long term opioid use defined as receiving an opioid on most days in a 90 day period
  • patients with a contraindication to spinal and regional anesthesia such as coagulopathy or infection at the site of the regional technique.

Location

  • UCLA Medical Center, Santa Monica accepting new patients
    Santa Monica California 90404 United States

Lead Scientist at UCLA

  • Pamela Chia, MD
    HS Assistant Clinical Professor, Anesthesiology, Medicine. Authored (or co-authored) 7 research publications

Details

Status
accepting new patients
Start Date
Completion Date
(estimated)
Sponsor
University of California, Los Angeles
Links
Sign up for this study
ID
NCT05247255
Phase
Phase 1 research study
Study Type
Interventional
Participants
Expecting 80 study participants
Last Updated
Contact us about this trial